Abstract
Receptor interacting protein 1 (RIP1) has a critical role in initiation of programmed necrosis or necroptosis. RIP1 in a close collaboration with RIP3 not only mediates necroptosis but also is involved in apoptosis and inflammatory signaling. However, the interpretation of the distinct function of RIP1 and RIP3 is complicated. Herein, we demonstrated that RIP1 inhibition in the context of LPS-induced neuroinflammation decreases RIP3 expression. Concomitant administration of Nec-1, specific inhibitor of RIP1, with LPS also attenuated the activating effect of RIP3 on metabolic enzymes, glutamate-ammonia ligase and glutamate dehydrogenase as bioenergetic determinants, in hippocampal and cortical cells. RIP1 inhibition possessed an anti-inflammatory effect and improved the antioxidant capacity against LPS. Interestingly, and opposed to some reports that necroptosis inhibition sensitizes cells to apoptosis, our results showed that RIP1 inhibition attenuates apoptotic cell death in response to LPS. The survival of neuronal function was also confirmed by measuring spontaneous alternations of rats in Y-maze. In conclusion, effects of RIP1 inhibition on RIP3 and cell death provide new approaches to ameliorate neuroinflammation and relative disorders.
Similar content being viewed by others
References
Aebi H (1984) Catalase in vitro. Methods Enzymol 105:121–126
Bradford M (1976) A rapid and sensitive method for the quantitation of microgram quantities of protein utilizing the principle of protein-dye binding. Anal Biochem 72:248–254
Cabal-Hierro L, Lazo PS (2012) Signal transduction by tumor necrosis factor receptors. Cell Signal 24:1297–1305. doi:10.1016/j.cellsig.2012.02.006
Chang P, Dong W, Zhang M, et al. (2014) Anti-necroptosis chemical necrostatin-1 can also suppress apoptotic and autophagic pathway to exert neuroprotective effect in mice intracerebral hemorrhage model. J Mol Neurosci 52:242–249. doi:10.1007/s12031-013-0132-3
Declercq W, Berghe TV, Vandenabeele P (2009) Minireview RIP kinases at the crossroads of cell death and survival. Cell 8:229–232
Degterev A, Huang Z, Boyce M, et al. (2005) Chemical inhibitor of nonapoptotic cell death with therapeutic potential for ischemic brain injury. Nat Chem Biol 1:112–119. doi:10.1038/nchembio711
Doherty D (1970) l-glutamate dehydrogenases (yeast). Methods Enzymol 17:850–856
Draper HH, Hadley M (1990) Malondialdehyde determination as index of lipid peroxidation. Methods Enzymol 186:421–431
Ellman GL (1959) Tissue sulfhydryl groups. Arch Biochem Biophys 82:70–77
Fricker M, Vilalta A, Tolkovsky AM, Brown GC (2013) Caspase inhibitors protect neurons by enabling selective necroptosis of inflamed microglia. J Biol Chem 288:9145–9152. doi:10.1074/jbc.M112.427880
Givens B (1995) Low doses of ethanol impair spatial working memory and reduce hippocampal theta activity. Alcohol Clin Exp Res 19:763–767
Gong Q, Wanga Q, Pan L, Liu X, Xin H, Zhu Y (2011) S-propargyl-cysteine, a novel hydrogen sulfide-modulated agent, attenuates lipopolysaccharide-induced spatial learning and memory impairment: involvement of TNF signaling and NF-jB pathway in rats. Brain Behav Immun 25:110–119
Guire C, Beyaert R, Loo G (2011) Death receptor signalling in central nervous system inflammation and demyelination. Trends Neurosci 34:619–628
Han W, Xie J, Li L, Liu Z, Hu X (2009) Necrostatin-1 reverts shikonin-induced necroptosis to apoptosis. Apoptosis 14:674–686. doi:10.1007/s10495-009-0334-x
Han W, Xie J, Fang Y, Wang Z, Pan H (2012) Nec-1 enhances shikonin-induced apoptosis in leukemia cells by inhibition of RIP-1 and ERK1/2. Int J Mol Sci 13:7212–7225. doi:10.3390/ijms13067212
Hou Y, Xie G, Miao F, et al. (2014) Pterostilbene attenuates lipopolysaccharide-induced learning and memory impairment possibly via inhibiting microglia activation and protecting neuronal injury in mice. Prog Neuro-Psychopharmacol Biol Psychiatry 54:92–102. doi:10.1016/j.pnpbp.2014.03.015
Iwai T, Iinuma Y, Kodani R, Oka J (2008) Neuromedin U inhibits inflammation-mediated memory impairment and neuronal cell-death in rodents. Neurosci Res 61:113–119. doi:10.1016/j.neures.2008.01.018
Kaiser WJ, Upton JW, Long AB, et al. (2011) RIP3 mediates the embryonic lethality of caspase-8-deficient mice. Nature 471:368–372. doi:10.1038/nature09857
Kakkar P, Das B, Viswanathan PN (1984) A modified spectrophotometric assay of superoxide dismutase. Indian J Biochem Biophys 21:130–132
Khan N, Lawlor K E, Murphy J M, Vince JE (2014) More to life than death: molecular determinants of necroptotic and non-necroptotic RIP3 kinase signaling. Curr Opin Immunol 26:76-89.
Kikuchi M, Kuroki S, Kayama M, Sakaguchi S, Lee KK, Yonehara S (2012) Protease activity of procaspase-8 is essential for cell survival by inhibiting both apoptotic and nonapoptotic cell death dependent on receptor-interacting protein kinase 1 (RIP1) and RIP3. J Biol Chem 287:41165–41173
Kim SJ, Li J (2013) Caspase blockade induces RIP3-mediated programmed necrosis in toll-like receptor-activated microglia. Cell Death Dis 4:e716. doi:10.1038/cddis.2013.238
Kimura R, Devi L, Ohno M (2010) Partial reduction of BACE1 improves synaptic plasticity, recent and remote memories in Alzheimer’s disease transgenic mice. J Neurochem 113:248–261. doi:10.1111/j.1471-4159.2010.06608.x
Kingdon HS, Hubbard JS, Stadtman ER (1968) Regulation of glutamine synthetase. XI The Nature and Implications of a lag Phase in the Escherichia coli Glutamine Synthetase Reaction Biochemistry 7:2136–2142
Miwa M, Tsuboi M, Noguchi Y, Enokishima A, Nabeshima T, Hiramatsu M (2011) Effects of betaine on lipopolysaccharide-induced memory impairment in mice and the involvement of GABA transporter 2. J Neuroinflammation 8:153. doi:10.1186/1742-2094-8-153
Niimura M, Takagi N, Takagi K, et al. (2006) Prevention of apoptosis inducing factor translocation is a possible mechanism for protective effects of hepatocyte growth factor against neuronal cell death in the hippocampus after transient forebrain ischemia. J Cereb Blood Flow Metabolism 26:1354–1365
Niranjan R (2013) Molecular basis of etiological implications in Alzheimer’s disease: focus on neuroinflammation. Mol Neurobiol 48:412–428. doi:10.1007/s12035-013-8428-4
Northington FJ, Chavez-Valdez R, Graham EM, Razdan S, Gauda EB, Martin LJ (2011) Necrostatin decreases oxidative damage, inflammation, and injury after neonatal HI. J Cereb Blood Flow Metab 31:178–189. doi:10.1038/jcbfm.2010.72
Oerlemans MI, Liu J, Arslan F, Den Ouden K, Van Middelaar BJ, Doevendans PA, Sluijter JP (2012) Inhibition of RIP1-dependent necrosis prevents adverse cardiac remodeling after myocardial ischemia reperfusion in vivo. Basic Res Cardiol 107:270–278
Ohno M, Sametsky EA, Younkin LH, et al. (2004) BACE1 deficiency rescues memory deficits and cholinergic dysfunction in a mouse model of Alzheimer’s disease. Neuron 41:27–33
Omidbakhsh R, Rajabli B, Nasoohi S, et al. (2014) Fingolimod affects gene expression profile associated with LPS-induced memory impairment. Exp Brain Res 232:3687–3696. doi:10.1007/s00221-014-4052-4
Paxinos G, Watson C (2007) The rat brain in stereotaxic coordinates. Elsevier Academic press, Amsterdam
Qinli Z, Meiqing L, Xia J, et al. (2013) Necrostatin-1 inhibits the degeneration of neural cells induced by aluminum exposure. Restor Neurol Neurosci 31:543–555. doi:10.3233/RNN-120304
Richman CL, Dember WN, Kim P (1987) Spontaneous alternation behavior: a review. Curr Psychol 5:385–391
Rosenbaum DM, Degterev A, David J, et al. (2010) Necroptosis, a novel form of caspase-independent cell death, contributes to neuronal damage in a retinal ischemia-reperfusion injury model. J Neurosci Res 88:1569–1576. doi:10.1002/jnr.22314
Takahashi N, Duprez L, Grootjans S, et al. (2012) Necrostatin-1 analogues : critical issues on the specificity, activity and in vivo use in experimental disease models. Cell Death Dis 3:e437–e410
Tricarico PM, Marcuzzi A, Piscianz E, Monasta L, Crovella S, Kleiner G (2013) Mevalonate kinase deficiency and neuroinflammation: balance between apoptosis and pyroptosis. Int J Mol Sci 14:23274–23288
Vandenabeele P, Galluzzi L, Vanden Berghe T, Kroemer G (2010) Molecular mechanisms of necroptosis: an ordered cellular explosion. Nat Rev Mol Cell Biol 11:700–714. doi:10.1038/nrm2970
Wang Y, Wang H, Tao Y, Zhang S, Wang J, Feng X (2014) Necroptosis inhibitor necrostatin-1 promotes cell protection and physiological function in traumatic spinal cord injury. Neuroscience 266:91–101. doi:10.1016/j.neuroscience.2014.02.007
Wyss-Coray T, Rogers J (2012) Inflammation in Alzheimer disease—a brief review of the basic science and clinical literature. Cold Spring Harb Perspect Med 2:a006346. doi:10.1101/cshperspect.a006346
Xu X, Chua CC, Kong J, Kostrzewa RM, Kumaraguru U, Hamdy RC, Chua B (2007) Necrostatin-1 protects against glutamate-induced glutathione depletion and caspase-independent cell death in HT-22 cells. J Neurochem 103:2004–2014
You Z, Savitz SI, Yang J, et al. (2008) Necrostatin-1 reduces histopathology and improves functional outcome after controlled cortical impact in mice. J Cereb Blood Flow Metab 28:1564–1573. doi:10.1038/jcbfm.2008.44
Zhang DW, Shao J, Lin J, et al. (2009) RIP3, an energy metabolism regulator that switches TNF-induced cell death from apoptosis to necrosis. Science 325:332–336. doi:10.1126/science.1172308
Zhou Y, Dai W, Lin C, et al. (2013) Protective effects of necrostatin-1 against concanavalin A-induced acute hepatic injury in mice. Mediat Inflamm 2013:706156. doi:10.1155/2013/706156
Acknowledgments
This work was carried out as part of a PhD project and financially supported by the Neuroscience Research Center, Shahid Beheshti University of Medical Sciences.
Author information
Authors and Affiliations
Corresponding author
Rights and permissions
About this article
Cite this article
Nikseresht, S., Khodagholi, F., Nategh, M. et al. RIP1 Inhibition Rescues from LPS-Induced RIP3-Mediated Programmed Cell Death, Distributed Energy Metabolism and Spatial Memory Impairment. J Mol Neurosci 57, 219–230 (2015). https://doi.org/10.1007/s12031-015-0609-3
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s12031-015-0609-3